Arrhythmogenic cardiomyopathy and Myocarditis – Dr Kostas Savvatis

This is a recording from the Cardiomyopathy UK 2022 Conference.
Our conference events bring together leading cardiomyopathy clinicians to present and respond to audience questions.
In this video, Dr Konstantinos ‘Kostas’ Savvatis discusses arrhythmogenic cardiomyopathy (ACM / AVC / ARVC / ALVC /ARVD) and myocarditis.

Key Topics:
Arrhythmogenic cardiomyopathy
00:00:19 – What does the arrhythmogenic cardiomyopathy heart look like?
00:01:26 – What do we mean by ‘arrhythmogenic cardiomyopathy’?
00:02:08 – How common is arrhythmogenic cardiomyopathy?
00:03:04 – What causes arrhythmogenic cardiomyopathy?
00:04:43 – How is arrhythmogenic cardiomyopathy inherited?
00:08:50 – How has the understanding of arrhythmogenic cardiomyopathy changed over time?
00:11:54 – What are the different arrhythmogenic cardiomyopathy phenotypes?
00:13:11 – What are the symptoms of arrhythmogenic cardiomyopathy?
00:15:36 – How is arrhythmogenic cardiomyopathy diagnosed?
00:18:33 – What imaging tools are used to diagnose arrhythmogenic cardiomyopathy?
00:19:40 – Genetic testing in arrhythmogenic cardiomyopathy
00:20:24 – What is the risk of sudden death in arrhythmogenic cardiomyopathy?
00:22:58 – What are the indications for an ICD in arrhythmogenic cardiomyopathy?
00:23:56 – How is arrhythmogenic cardiomyopathy managed with an ICD?
00:25:15 – Which ICD should someone with arrhythmogenic cardiomyopathy have?
00:26:06 – How is risk assessed in arrhythmogenic cardiomyopathy?
00:28:01 – What are the psychological implications of having an ICD?
00:29:14 – What are the exercise restrictions in arrhythmogenic cardiomyopathy?
00:34:39 – Heart failure in arrhythmogenic cardiomyopathy
00:35:36 – What is ablation used for in arrhythmogenic cardiomyopathy?
00:36:29 – What is the treatment for arrhythmogenic cardiomyopathy?
00:37:51 – What is the role of family screening in arrhythmogenic cardiomyopathy?
00:38:41 – What does the future of arrhythmogenic cardiomyopathy look like?
Myocarditis
00:39:54 – What is myocarditis?
00:40:38 – How common is myocarditis?
00:41:46 – How does myocarditis present?
00:42:33 – What are the causes of myocarditis?
00:44:10 – What happens to the heart in myocarditis?
00:45:21 – What are the symptoms of myocarditis?
00:47:47 – What is the prognosis for myocarditis?
00:48:59 – What is Giant Cell myocarditis?
00:49:20 – Is there a connection between COVID and myocarditis?
00:50:11 – What is the treatment for myocarditis?
00:50:54 – What are the exercise recommendations for myocarditis?
00:51:51 – Conclusions
Audience questions
00:53:04 – In arrhythmogenic cardiomyopathy, is exercise restricted based upon ejection fraction?
00:56:57 – Can tachycardia-induced cardiomyopathy lead to arrhythmogenic cardiomyopathy?
01:01:34 – Should arrhythmogenic cardiomyopathy gene-carrying children be exercise-restricted?
01:04:36 – Are ablations used in arrhythmogenic cardiomyopathy only in the later stages of the disease? Are there alternatives?
01:07:52 – Will new drugs such as dapagliflozin / empagliflozin be used to treat arrhythmogenic cardiomyopathy? What are the implications of the recently announced https://cureheart.web.ox.ac.uk/ project?
01:15:06 – What are the challenges in differentiating cardiac sarcoidosis from arrhythmogenic cardiomyopathy? How do the prognosis and treatment differ?
01:18:08 – If a family member is gene-tested and found not to carry the gene, does that mean there is no further follow-up required?
01:19:26 – If a family member has been genetically screened, but no gene was found, should they be retested based on new gene panels?
01:22:33 – Are there any early indications in young people that they may have arrhythmogenic cardiomyopathy?

Access free information, find out about support groups and speak with cardiomyopathy Specialist Nurses at www.cardiomyopathy.org